|1.||Huang, Tiao-Lai: 10 articles (11/2013 - 04/2004)|
|2.||Ely, E Wesley: 8 articles (03/2012 - 01/2004)|
|3.||Silbergleit, Robert: 6 articles (08/2015 - 10/2011)|
|4.||Durkalski, Valerie: 5 articles (08/2015 - 10/2011)|
|5.||Hung, Yi-Yung: 5 articles (01/2013 - 04/2006)|
|6.||Girard, Timothy D: 5 articles (03/2012 - 01/2007)|
|7.||Shintani, Ayumi K: 5 articles (03/2012 - 01/2007)|
|8.||Conwit, Robin: 4 articles (02/2015 - 10/2011)|
|9.||MacLaren, Robert: 4 articles (05/2014 - 10/2005)|
|10.||Thompson, Jennifer L: 4 articles (03/2012 - 12/2007)|
06/01/1990 - "Our data confirmed clinical reports of lorazepam's effectiveness as a treatment for SE and suggest that a target serum concentration of 200 ng/ml should be effective in most cases and provide seizure protection for 24 hours following treatment."
03/25/1999 - "Treatment with intravenous lorazepam is associated with a significant reduction in the risk of recurrent seizures related to alcohol."
02/01/1984 - "With lorazepam there was a significant reduction in seizures, especially in those with focal and partial complex attacks. "
11/01/2014 - "The efficacy of sublingual Lorazepam for prolonged convulsions beyond sub-saharan Africa: raising more questions than answers."
10/01/1991 - "The diagnosis of seizures and the efficacy of treatment was assessed clinically and by EEG during the administration of lorazepam in three patients and on clinical grounds in four patients. "
04/01/2006 - "Lorazepam is effective in rapidly relieving most cases of catatonia. "
02/01/2005 - "The uses of lorazepam and electroconvulsive therapy (ECT) have been proven to be effective in treating catatonia. "
01/01/2010 - "In this report, we describe two renal-insufficient patients with catatonia who had a good response to intramuscular lorazepam whereby the catatonic symptoms were relieved. "
01/01/2007 - "He was diagnosed with catatonia and was treated successfully with lorazepam. "
08/01/1996 - "Each of the five showed pronounced and rapid improvement after administration of low-dose lorazepam, which has previously been reported to be effective in the treatment of catatonia. "
07/01/2002 - "This article reviews improvements made in antiemetic therapy and considers how the addition of lorazepam may further optimize the prevention and management of emesis at various stages of manifestation."
01/01/1996 - "The incidence of vomiting in the lorazepam group was significantly lower than in the placebo group (14.5% vs 45%). "
06/01/1991 - "Control of vomiting was achieved is 55% (complete 5%, partial 50%) of the patients receiving MCP alone and in 100 percent (complete 76.1%; partial 23.8%) of those receiving MCP plus lorazepam (p less than 0.001). "
07/01/2002 - "An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy."
12/01/1984 - "Lorazepam for chemotherapy-induced emesis."
|4.||Status Epilepticus (Complex Partial Status Epilepticus)
08/01/2009 - "The authors convened concurrent focus groups of research staff and investigators involved in a pharmacokinetic study of lorazepam for status epilepticus (SE). "
01/01/1983 - "Clinical studies of lorazepam in status epilepticus."
09/01/2012 - "There was a wide variability in the management of status epilepticus, and intravenous lorazepam was underutilised."
09/01/2012 - "Status epilepticus occurred on 12 occasions (4.7%) with only three patients receiving lorazepam as treatment. "
04/01/2012 - "To evaluate the single dose pharmacokinetics of an intravenous dose of lorazepam in pediatric patients treated for status epilepticus (SE) or with a history of SE. "
01/01/1996 - "Lorazepam reduced the incidence and especially the intensity of nausea. "
04/30/1993 - "However, nausea was shorter in lorazepam arm (p < 0.01), and 80% of the patients preferred treatment with lorazepam (p < 0.003). "
01/01/1991 - "Patients who received lorazepam had, however, significantly fewer nausea episodes during first day post-chemotherapy (p less than 0.05). "
10/01/1994 - "Crossover analysis showed a highly significant effect of lorazepam in reducing the severity of nausea (p = .003); the severity of vomiting was also reduced, but less dramatically (p = .051). "
10/01/1994 - "The frequency of all degrees of nausea and vomiting was less with lorazepam, but the difference was not statistically significant. "
|1.||Drug Therapy (Chemotherapy)